Catalyst Wire Dossier Catalyst Wire Dossier

ICOSAPENT ETHYL

icosapent ethyl · Qilu Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for ICOSAPENT ETHYL, covering 2020-05-21 to 2025-10-03. Get the full timeline:

Most recent: Clinical Trial Update: IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion [Phase 2]

See pricing